Search alternatives:
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
linear decrease » linear increase (Expand Search)
teer decrease » mean decrease (Expand Search)
i marked » _ marked (Expand Search), _ market (Expand Search), _ marker (Expand Search)
increase » increased (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
linear decrease » linear increase (Expand Search)
teer decrease » mean decrease (Expand Search)
i marked » _ marked (Expand Search), _ market (Expand Search), _ marker (Expand Search)
increase » increased (Expand Search)
-
1
Studies exploring a relationship between <i>Shigella</i> infection and decreased linear growth/stunting or growth measures in young children and other relevant outcomes.
Published 2023“…<p>Studies exploring a relationship between <i>Shigella</i> infection and decreased linear growth/stunting or growth measures in young children and other relevant outcomes.…”
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Vajira Hospital
Published 2025“…S2 File - <p>Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Vajira Hospital</p>…”
-
11
Deletion of Hhp2 markedly increased Sre1 activity.
Published 2020“…<p>Deletion of <i>hhp2</i><sup>+</sup> gene markedly increased Sre1 activity in the presence/absence of CLZ (2 μg/ml to 8 μg/ml) (A), TER (2 μg/ml to 8 μg/ml) (B) or CoCl<sub>2</sub> (0.08 mM to 0.32 mM) (C). …”
-
12
Linear regression analysis.
Published 2025“…</p><p> Conclusion </p><p>The HTRT group showed a greater decrease in HU both pre- and post-treatment, indicating a possible indirect marker of tumor necrosis. …”
-
13
-
14
-
15
-
16
-
17
Withdrawal of Type I JAKinibs increased STAT phosphorylation, a phenomenon present but markedly lower in Type II JAKinibs.
Published 2025“…(A) pJAK2 peaked at time zero after exposure to baricitinib and ruxolitinib and then decreases. …”
-
18
-
19
Decrease in preferred walking speed with distance walked for subjects with amputation.
Published 2024“…<p>a) Subjects with amputation showed a decrease in average preferred walking speed for short distances. b) The rate of change in preferred walking speed with distance for the subjects with unilateral amputation is shown over a regime where both the subject-averaged data and the model fit are well-fit by linear trends (<i>R</i><sup>2</sup> value greater than 95%).…”
-
20